James Wasson
Obstetrics & Gynecology · Tyler, TXNPI 1598736829
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 34.0% of the total. Reporting peaked in 2021 at $596 and has fallen 53.1% since, to $279 in 2025.
Across 126 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$810
- Mayne Pharma Commercial LLC$176
- Myovant Sciences Inc.$115
- Idorsia Pharmaceuticals US Inc$112
- Exeltis, USA Inc.$111
- Shield Therapeutics Inc$91
- plus $965 from 25 others
What the payments were for
- Food & beverage$2,28096%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $810 |
| Mayne Pharma Commercial LLC | 2 | $176 |
| Myovant Sciences Inc. | 6 | $115 |
| Idorsia Pharmaceuticals US Inc | 6 | $112 |
| Exeltis, USA Inc. | 6 | $111 |
| Shield Therapeutics Inc | 5 | $91 |
| Mission Pharmacal Company | 5 | $91 |
| Astellas Pharma US Inc | 1 | $85 |
| Hologic Sales And Service, LLC | 3 | $74 |
| Vertex | 3 | $70 |
| Lupin Inc. | 4 | $66 |
| Therapeuticsmd, Inc. | 4 | $65 |
| Novo Nordisk | 3 | $61 |
| Novartis | 3 | $55 |
| Lilly USA, LLC | 3 | $47 |
| Avion Pharmaceuticals | 3 | $43 |
| Scynexis, Inc. | 2 | $42 |
| Sage Therapeutics, LLC | 2 | $33 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences | 1 | $22 |
| Medtronic | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $19 |
| Organon | 2 | $19 |
| Bayer | 1 | $18 |
| BD | 1 | $17 |
| Avanos Medical | 1 | $16 |
| Duchesnay USA Incorporated | 1 | $15 |
| Pfizer | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Gilead | 1 | $12 |
How this compares
$2,380 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 26 | $184 |
| Simvastatin | 17 | $165 |
| Labetalol Hcl | 12 | $156 |
| Amlodipine Besylate | 12 | $42 |
| Alprazolam | 11 | $37 |
| Hydrochlorothiazide | 19 | $33 |
| Levothyroxine Sodium | 11 | $25 |
| Metformin Hcl | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Tyler
- Ralph TurnerTyler$54K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.